Replies to post #94395 on Ayala Pharmaceuticals Inc (fka ADXS)

[hovacre]

As a result, the Company adjusted its measure of progress for its performance obligations under the collaboration agreement and, based on the modified service period, reported incremental revenue of $15.6 million in the first quarter of fiscal year 2019